<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Organon LLC et al v. Encube Ethicals Limited :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2026cv01101/94451</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2026cv01101/94451/feed" rel="self" type="application/rss+xml" />
        <pubDate>Sat, 05 Sep 2026 16:05:17 -0700</pubDate>
        <lastBuildDate>Sat, 05 Sep 2026 16:05:17 -0700</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Organon LLC et al v. Encube Ethicals Limited - Docket Entries - Showing 1 through 6</description>
                                    <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued as to Encube Ethicals Limited on 9/1/2026. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_37221066</guid>
                <pubDate>
            Tue, 01 Sep 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Organon & Co. as a member for Dermavant Sciences GmbH, Organon International GmbH, Organon LLC. Organon International Holdings B.V. is the owner of Organon International GmbH, and Dermavant Holdings Limited is the owner of Dermavant Sciences GmbH. Organon & Co. is the ultimate parent company of each of those entities. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_37221067</guid>
                <pubDate>
            Tue, 01 Sep 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,195,160 B2; 10,426,743 B2; 10,647,649 B2; 11,458,108 B2; 11,497,718 B2; 11,590,088 B2; 11,597,692 B2; 11,612,573 B2; 11,617,724 B2; 11,622,945 B2; 11,938,099 B2; 12,569,453 B2. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_37221068</guid>
                <pubDate>
            Tue, 01 Sep 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/22/2026. Dates of Expiration of Patent: U.S. Patent No. 10,195,160 expires May 23, 2036; U.S. Patent Nos. 10,426,743, 11,458,108, 11,612,573, 11,617,724, 11,622,945 expire on May 19, 2036; U.S. Patent Nos. 10,647,649, 11,497,718, 11,590,088, 11,597,692, 11,938,099 expire on November 13, 2038; and U.S. Patent No. 12,569,453 expires on December 18, 2039. Thirty Month Stay Deadline: 11/23/2029. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_37221069</guid>
                <pubDate>
            Tue, 01 Sep 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aas)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_37221070</guid>
                <pubDate>
            Tue, 01 Sep 2026 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT for Patent Infringement against Encube Ethicals Limited (Filing fee $ 405, receipt number ADEDC-5054952) - filed by Organon LLC, Organon International GmbH, and Dermavant Sciences GmbH. (Attachments: #1 Exhibits 1-12, #2 Civil Cover Sheet)(aas) Modified on 9/1/2026 (nms).
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_37221071</guid>
                <pubDate>
            Tue, 01 Sep 2026 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
